Infusion Pump Market

The report "Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030", is projected to reach USD 28.3 billion by 2030 from USD 19.9 billion in 2025, growing at a CAGR of 7.4%.

Browse 608 market data Tables and 86 Figures spread through 582 Pages and in-depth TOC on "Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/infusion-pumps-accessories-market-90374506.html

The rapid expansion of the infusion pump market can be attributed to several key factors, including technological advancements, evolving healthcare delivery models, and demographic shifts. The introduction of sophisticated, interconnected infusion systems has been transformative, as these devices integrate seamlessly with electronic health records (EHRs) and hospital IT infrastructures. This integration facilitates precise dosing, enables real-time monitoring, and enhances clinical decision-making capabilities, improving patient safety and streamlining healthcare providers' workflows. Moreover, regulatory agencies globally are intensifying their focus on safety and cybersecurity standards pertinent to infusion pumps. Given the critical role these devices play in administering a wide range of medications, stringent regulations are in place to mitigate risks associated with medication errors and cybersecurity threats. Another significant driver of market growth is the transition of treatment modalities from hospital environments to home care settings, particularly for chronic conditions such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders. This trend aligns with the increasing global geriatric population that is more susceptible to such chronic ailments and often favors home care for long-term management. These elements are reshaping the infusion therapy landscape, highlighting the intersection of technological innovation, regulatory evolution, and patient-centric care models.

"By type, the accessories & consumables segment accounted for the largest market share in 2024."

By type, the accessories & consumables segment accounted for a larger market share in 2024. The substantial market share attributed to infusion pump disposables is primarily linked to their critical role in ensuring safe and effective medication administration through recurrent use. This category encompasses essential components such as infusion sets, catheters, tubing, and connectors, all of which are single-use items that require regular replacement to maintain patient safety and minimize infection risk. The necessity for routine replenishment significantly drives their market demand. The rising incidence of chronic conditions, including diabetes, cancer, and autoimmune diseases, has resulted in an escalating need for infusion therapies, thereby intensifying the demand for disposable components associated with infusion pumps. Given that infusion pumps are utilized across diverse healthcare settings—from hospitals to home healthcare and ambulatory centers—there is a pressing need for high-quality, compatible accessories. This demand trajectory is a critical factor propelling the growth of this market segment.

"By application, the diabetes management segment is expected to grow at the fastest CAGR in the market during the forecast period."

The rapid expansion of the diabetes management segment is primarily driven by the increasing prevalence of diabetes, alongside significant technological advancements in infusion pump devices, notably insulin pumps. A key factor propelling this segment forward is the emergence of sophisticated insulin delivery systems, specifically hybrid closed-loop systems, commonly referred to as artificial pancreas devices. These systems effectively integrate continuous glucose monitoring (CGM) with automated insulin delivery, allowing for precise adjustments to insulin dosages based on real-time glucose levels. Developments in accessible insulin pumps are noteworthy, characterized by touchscreen interfaces, customizable basal insulin rates, and seamless integration with mobile applications, all of which enhance patient adherence to treatment protocols. Additionally, the escalating incidence of diabetes can be attributed to several contributing factors, including a growing geriatric demographic, increased consumption of alcohol and tobacco, and evolving lifestyle and dietary patterns, further fueling market growth in this domain.

“By region, North America accounted for the largest share of the market in 2024.”

In 2024, North America emerged as the dominant player in the infusion pump market, primarily driven by substantial healthcare expenditures in the US. The Centers for Medicare & Medicaid Services (CMS) reported that US healthcare spending reached approximately USD 4.9 trillion in 2023, facilitating the uptake of advanced medical technologies such as smart infusion pumps across diverse healthcare environments. The region's robust healthcare infrastructure further bolsters its market presence with an extensive network of hospitals and outpatient facilities equipped with state-of-the-art medical devices, including sophisticated infusion pump systems. Major manufacturers such as Becton, Dickinson and Company (BD), Baxter, and ICU Medical, all headquartered in the US, enhance access to innovative infusion technologies, accelerating market advancements. Moreover, the rising prevalence of chronic diseases and a growing geriatric population are additional catalysts for market growth, creating an increased demand for reliable infusion solutions. This synergy of high healthcare investment, advanced infrastructure, and an expanding patient demographic solidifies North America's position as a global infusion pump market leader.

Key Market Players

Prominent players in the infusion pump market are Becton, Dickinson and Company (US), Baxter (US), B. Braun SE (Germany), ICU Medical, Inc. (US), Fresenius Kabi AG (Germany), Medtronic (Ireland), Terumo Corporation (Japan), NIPRO (Japan), AVNS (US), and Insulet Corporation (US).

Don’t miss out on business opportunities in Infusion Pump Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/